Published in J Thorac Cardiovasc Surg on September 01, 2007
Identification of independent primary tumors and intrapulmonary metastases using DNA rearrangements in non-small-cell lung cancer. J Clin Oncol (2014) 1.67
The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours. Eur J Nucl Med Mol Imaging (2010) 1.00
Photodynamic therapy for the treatment of non-small cell lung cancer. J Thorac Dis (2012) 0.99
Photodynamic therapy for lung cancer and malignant pleural mesothelioma. Semin Oncol (2014) 0.92
Heterogeneity of Programmed Cell Death Ligand 1 Expression in Multifocal Lung Cancer. Clin Cancer Res (2015) 0.87
Multiple synchronous primary tumours in a single lobe. Interact Cardiovasc Thorac Surg (2011) 0.84
Clinical features of multiple lung cancers based on thin-section computed tomography: what are the appropriate surgical strategies for second lung cancers? Surg Today (2014) 0.82
Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging. Mod Pathol (2016) 0.81
Early clinical diagnosis of synchronous multiple primary lung cancer. Oncol Lett (2011) 0.81
Utility of Genomic Analysis in Differentiating Synchronous and Metachronous Lung Adenocarcinomas from Primary Adenocarcinomas with Intrapulmonary Metastasis. Transl Oncol (2017) 0.75
Two synchronous non small cell lung carcinomas with different morphologies in the same lobe. J Surg Case Rep (2012) 0.75
Significance of nonmucinous lepidic component with mild nuclear atypia in the discrimination of multiple primary lung cancers from intrapulmonary metastases. Int J Clin Exp Pathol (2014) 0.75
SUVmax and Tumor Size Predict Surgical Outcome of Synchronous Multiple Primary Lung Cancers. Medicine (Baltimore) (2016) 0.75
Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers. Sci Rep (2016) 0.75
Targeted sequencing may facilitate differential diagnostics of pulmonary tumours: a case series. Diagn Pathol (2017) 0.75
Method for discriminating synchronous multiple lung cancers of the same histological type: miRNA expression analysis. Medicine (Baltimore) (2016) 0.75
MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell (2008) 5.34
Nonintubated thoracoscopic lobectomy for lung cancer. Ann Surg (2011) 2.54
p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat Cell Biol (2009) 2.35
Significance of extranodal extension of regional lymph nodes in surgically resected non-small cell lung cancer. Chest (2007) 2.18
Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin Cancer Res (2003) 1.89
Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma. Clin Cancer Res (2005) 1.84
MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. Nat Commun (2013) 1.76
Thymectomy for non-thymomatous myasthenia gravis: a comparison of surgical methods and analysis of prognostic factors. Eur J Cardiothorac Surg (2009) 1.66
Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer. J Clin Oncol (2002) 1.63
Extensive tracheobronchitis and lung perforation after alkaline caustic aspiration. Ann Thorac Surg (2010) 1.55
The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers. J Thorac Cardiovasc Surg (2005) 1.55
Additional minocycline pleurodesis after thoracoscopic surgery for primary spontaneous pneumothorax. Am J Respir Crit Care Med (2005) 1.53
The morphology of diaphragmatic defects in hepatic hydrothorax: thoracoscopic finding. J Thorac Cardiovasc Surg (2005) 1.51
Salvage for unsuccessful aspiration of primary pneumothorax: thoracoscopic surgery or chest tube drainage? Ann Thorac Surg (2008) 1.48
Expression of the estrogen receptor beta in 37 surgically treated pulmonary sclerosing hemangiomas in comparison with non-small cell lung carcinomas. Hum Pathol (2005) 1.44
The ability of LCRMP-1 to promote cancer invasion by enhancing filopodia formation is antagonized by CRMP-1. J Clin Invest (2011) 1.44
Cancer-specific activation of the survivin promoter and its potential use in gene therapy. Cancer Gene Ther (2004) 1.32
Mature mediastinal teratoma: sonographic imaging patterns and pathologic correlation. J Ultrasound Med (2002) 1.30
Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma. Am J Respir Crit Care Med (2008) 1.29
Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers. Clin Cancer Res (2007) 1.22
Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction. PLoS One (2011) 1.21
Comparison of manual and mechanical cervical esophagogastric anastomosis after esophageal resection for squamous cell carcinoma: a prospective randomized controlled trial. Eur J Cardiothorac Surg (2004) 1.20
Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour. J Pathol (2015) 1.14
Pulmonary resection for colorectal cancer metastases: duration between cancer onset and lung metastasis as an important prognostic factor. Ann Surg Oncol (2009) 1.11
EGFR and p53 status of pulmonary pleomorphic carcinoma: implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy. Ann Surg Oncol (2011) 1.10
Needlescopic versus conventional video-assisted thoracic surgery for primary spontaneous pneumothorax: a comparative study. Ann Thorac Surg (2003) 1.09
Infected bronchogenic cyst due to Mycobacterium avium in an immunocompetent patient. J Infect (2004) 1.08
Unique p53 and epidermal growth factor receptor gene mutation status in 46 pulmonary lymphoepithelioma-like carcinomas. Cancer Sci (2010) 1.08
Association of GSTP1 polymorphism and survival for esophageal cancer. Clin Cancer Res (2005) 1.06
Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery. Ann Surg Oncol (2011) 1.05
Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients. Int J Cancer (2005) 1.04
Non-functional paraganglioma of the posterior mediastinum. Interact Cardiovasc Thorac Surg (2009) 1.04
Video-assisted thoracoscopic excision of intradiaphragmatic bronchogenic cysts: two cases. J Laparoendosc Adv Surg Tech A (2006) 1.04
The significance of visceral pleural surface invasion in 321 cases of non-small cell lung cancers with pleural retraction. Ann Surg Oncol (2012) 1.02
Cystic malignant teratoma with early recurrence after intraoperative spillage. Ann Thorac Surg (2008) 1.02
New aspects in clinicopathologic and oncogene studies of 23 pulmonary lymphoepithelioma-like carcinomas. Am J Surg Pathol (2002) 1.02
The tumor suppressor DAPK is reciprocally regulated by tyrosine kinase Src and phosphatase LAR. Mol Cell (2007) 1.01
The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. Lung Cancer (2004) 1.01
Comparison of p53 and epidermal growth factor receptor gene status between primary tumors and lymph node metastases in non-small cell lung cancers. Ann Surg Oncol (2010) 0.99
A huge cystic cellular schwannoma of the intercostal nerve presenting with dyspnea. Ann Thorac Surg (2009) 0.99
Sialyl Lewis antigens: association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancer. Lung Cancer (2005) 0.97
TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma. EMBO Mol Med (2012) 0.97
Pleurocutaneous fistula after tube thoracostomy: sonographic findings. J Clin Ultrasound (2008) 0.97
Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys (2011) 0.96
Is there any benefit to incorporating a laparoscopic procedure into minimally invasive esophagectomy? The impact on perioperative results in patients with esophageal cancer. World J Surg (2011) 0.96
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study. J Surg Oncol (2008) 0.96
Long form collapsin response mediator protein-1 (LCRMP-1) expression is associated with clinical outcome and lymph node metastasis in non-small cell lung cancer patients. Lung Cancer (2010) 0.95
Resection of a giant thoracic solitary fibrous tumor through two separate thoracotomies. J Thorac Cardiovasc Surg (2008) 0.95
Prognostic factors for pulmonary metastasectomy in hepatocellular carcinoma. Ann Surg Oncol (2006) 0.94
18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: is dual time point imaging worth the effort? Eur J Nucl Med Mol Imaging (2008) 0.94
Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis. Eur Respir J (2012) 0.94
SULT1A1 polymorphism and esophageal cancer in males. Int J Cancer (2003) 0.93
Surgical lung biopsy for diffuse pulmonary disease: experience of 196 patients. J Thorac Cardiovasc Surg (2005) 0.92
Association of angiotensin-converting enzyme insertion/deletion polymorphism with serum level and development of pulmonary complications following esophagectomy. Ann Surg (2005) 0.92
Effects of additional minocycline pleurodesis after thoracoscopic procedures for primary spontaneous pneumothorax. Chest (2004) 0.92
RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts. Oncogene (2004) 0.91
Extracorporeal membrane oxygenation in pulmonary crisis and primary graft dysfunction. J Heart Lung Transplant (2008) 0.90
Comparison of the quality of life between patients with non-small-cell lung cancer and healthy controls. Qual Life Res (2010) 0.90
Descending necrotizing mediastinitis: a 10-year surgical experience in a single institution. J Thorac Cardiovasc Surg (2008) 0.90
Genetic variants in DNA repair predicts the survival of patients with esophageal cancer. Ann Surg (2011) 0.89
Management of recurrent primary spontaneous pneumothorax after thoracoscopic surgery: should observation, drainage, redo thoracoscopy, or thoracotomy be used? Surg Endosc (2009) 0.88
Specific induction of the high-molecular-weight microtubule-associated protein 2 (hmw-MAP2) by betel quid extract in cultured oral keratinocytes: clinical implications in betel quid-associated oral squamous cell carcinoma (OSCC). Carcinogenesis (2003) 0.88
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma. J Thorac Oncol (2012) 0.88
Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy. Ann Surg Oncol (2009) 0.88
The significance of E-cadherin and alpha-, beta-, and gamma-catenin expression in surgically treated non-small cell lung cancers of 3 cm or less in size. J Thorac Cardiovasc Surg (2002) 0.87
Short-term outcomes of cadaveric lung transplantation in ventilator-dependent patients. Crit Care (2009) 0.87
Dedifferentiated liposarcoma with homologous lipoblastic differentiation: expanding the spectrum to include low-grade tumours. Histopathology (2013) 0.87
Diffuse pulmonary infiltrates after bone marrow transplantation: the role of open lung biopsy. Ann Thorac Surg (2004) 0.86
Aggressive management of massive hemothorax in patients on extracorporeal membrane oxygenation. Asian J Surg (2012) 0.85
Angiomyofibroblastoma of the vulva. J Formos Med Assoc (2004) 0.85
Validation of a computer-based bronchoscopy simulator developed in Taiwan. J Formos Med Assoc (2006) 0.84
Elevation of telomerase activity positively correlates to poor prognosis of patients with non-small cell lung cancer. Cancer Lett (2005) 0.83
Using Surgicel to buttress the staple line in lung volume reduction surgery for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg (2006) 0.83
Perioperative extracorporeal membrane oxygenation support for critical pediatric airway surgery. Eur J Pediatr (2007) 0.82
18 years surgical experience with mediastinal mature teratoma. J Formos Med Assoc (2010) 0.82
Catheter-related septicemia due to Aureobasidium pullulans. Int J Infect Dis (2008) 0.82
Phosphorylation of LCRMP-1 by GSK3β promotes filopoda formation, migration and invasion abilities in lung cancer cells. PLoS One (2012) 0.82
Pulmonary infection due to Mycobacterium marinum in an immunocompetent patient. Clin Infect Dis (2005) 0.82
Supine position with alternating inflation pneumatic cuffs in video-assisted thoracoscopic surgery for bilateral pneumothorax. J Thorac Cardiovasc Surg (2005) 0.82
Pediatric empyema: Outcome analysis of thoracoscopic management. J Thorac Cardiovasc Surg (2009) 0.81
Significance of tumor satellite variables in reflecting the epithelial-mesenchymal transition of tongue cancer. Oral Oncol (2011) 0.81
Use of germline polymorphisms in predicting concurrent chemoradiotherapy response in esophageal cancer. Int J Radiat Oncol Biol Phys (2011) 0.81
Patterns, effects, and thoracic volume changes of thoracoscopic pleurodesis in rabbits. J Surg Res (2007) 0.81
Response of refractory osteosarcoma to thalidomide and celecoxib. Lancet Oncol (2005) 0.81
Primary pulmonary plasmacytoma with immunoglobulin G/lambda light chain monoclonal gammopathy. J Thorac Cardiovasc Surg (2006) 0.81
Staged dilation and stenting for long segmental tracheobronchial stenosis caused by tuberculosis. J Thorac Cardiovasc Surg (2003) 0.81
Potential roles of fibroblast growth factor-9 in the benzo(a)pyrene-induced invasion in vitro and the metastasis of human lung adenocarcinoma. Arch Toxicol (2010) 0.80
Pulmonary manifestations and management of proteus syndrome. J Formos Med Assoc (2010) 0.80